NorthWest Biotherapeutics Inc (NWBO)

[hyperopia]

I think your question whether the MHRA would approve DCVax based on manual production was strictly from a manufacturing perspective, but in my mind there was a question of NICE’s cost analysis based on manual manufacturing that would then change considerably once automated manufacturing was approved. Now I think we have an answer how this can be accomplished: The Cancer Drugs Fund/Innovative Medicines Fund can fund the treatments until a final (long-term) cost assessment can be made based on automated manufacturing.